Member Info for ShareSting

Miggy007 you are 100% correct. It is solid and covers outside of just COPD and Asthma, it 100% covers a virus like Corona.

So there have been some churn today, which would be expected given some placement shares are swopping
hands. However it is the mega buys that interest me. 230k buy is no PI punter, even the 50k buys are likely to be someone allot bigger than us !
I’m expecting some mega after hours activity again today. GLA !

Thank you to all the trolls and rainbow chasers for selling this morning. It has allowed me to top up at a level I didn’t think would be possible before news.

Announcements on trial and next steps for the business will land when most don’t expect it.

I believe this is now the most exciting share on AIM.

Accelerated Clinical Study, Strong Patents Granted, Proven technology in similar field.

Looks good to me !

Around £1.7m worth of delayed trades in total from yesterday just appeared.

Yes this drug has some nasty side effects.
With this virus doctors have to be so careful, as some treatments have accelerated the virus rather than stop.

That is one benefit of SNG001, we are supporting the bodies fight, rather than tampering with the immune response system.

SNG001 will work. However as I have said before, what is the % of success. We don’t need 100% success here. 50% would be quite remarkable.

Patent !

So with more shares in issue 26m existing holders get diluted. LINK has not sold any.

What a difference a few hours make. Last night this board was full of quality posts and research. Now it is being spammed by idiots. Such a shame LSE let this happen.

This was the Times journalist that covered us back on the 29th March. If we all tweet her, that might trigger something.

The press have not yet picked up on the NIHR news !
I am surprised that this has not hit any newspapers yet.

Both PI’s and Press don’t understand quite how big this is going to be.

Following on from my posts last night I want to just repeat the fact that SNG001 is now being reviewed by internationally recognised experts in Respiratory Translation Research Collaboration.

Research is being accelerated into SNG001. Funding will also be made available.

I am surprised Press have not picked up on this yet.

I have added more to my holding this morning. I believe the MCAP of this company will steadily rise. I think on positive news we will see a MCAP of £500m.

Good luck genuine holders.

There were some excellent posts last night (including mine) which highlights why we should all remain confident regarding the Urgent upscale of our trials.

This list of doctors posted last night are some of the best in the world and they now have eyes on SNG001!

We are due further updates from Richard soon. I would expect news on ongoing multinational discussions to land within the next week max.

I have also emailed Richard to see if he can explain in more detail the importance of the upscale announcement yesterday.

I’m expecting a gap up today and a test of 80p.

Let’s not forget SNG001 has to work to save life’s. the world is looking for good news, I truly think Synairgen have the answers.

I am.. you are very correct on both fronts.
What value do you put on saving life’s not only in the UK but across the globe ?
Also regarding your comment on meetings, Richard has been in talks all weekend.
None of us know how this will progress, but if it saves life’s and everyone here hopes it does, the MCAP of SNG has an opportunity to x10 from where we are today.

Things are now being accelerated, so news might land sooner than most think.

They have 3 working days to inform the market.

SNG001 has been adopted by NIHR Respiratory Translational Research Collaboration, which is comprised of leading centres in respiratory medicine in the UK who’s internationally recognised experts are working together to accelerate development and discovery for Covid19. A successful outcome from the pilot phase will inform onwards progression of SNG001 in Covid19 patients.

From the RNS notes page !
This is looking stronger than ever.

Wrong board for that question!

That is the number of shares traded today. Over 10% of the company or 20% of free issue shares. (43% are in major shareholder hands ( excluding directors))

The company is now at risk of a hostile approach. It is important to see the value rise above £100m over the next week. It is also important to attract Institution Investors. It will be interesting to see if there are any TR1’s tomorrow of the back of the new shares.

So things are hotting up for sure. The RNS was very clever today with a subtle hint that things are progressing positively. This is excellent news as we are on the way to saving life’s !

Synairgen or more likely SNG001 will be known throughout the world soon. This is no ramp, no pump and dump, just based of solid facts, bullet proof patents and historic data.

Did you notice the delayed trades also from Thursday !!!

Good luck all.

Trolls starting to appear.
They have zero research!
We could see a TR1 tomorrow as existing and new holders take delivery of their 30m shares.
They were bought by directors, II’s and PI’s.
they were in very short supply.
Most will hold. Some will have forward sold and a few might sell tomorrow. HOWEVER buyers will continue to buy and after today’s under reported news, we can expect a very quick update to land later this week / early next !

Anyone asking if this will pick back up don’t understand this company and where it is going !

The MCAP is under £100m. It will be 10 times this if results are as good as I forecast.

The announcement today is mega. But not understood by most !

Any attempt at comparing SNG to others being pumped is pointless. SNG have GRANTED PATENTS, WHO NACKED CLINICAL TRIALS and today the backing of NIHR.
We also have extremely valuable historic data and safety studies.
Not many can compete with this list !